Aims and scope

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports.

Although the primary focus is Alzheimer's dementia, the scope encompasses translational research into other neurodegenerative diseases.

Featured research article: Alzheimer’s and a shrinking hippocampus

In this study, Aaron Bonner-Jackson and colleagues examine the relationship between episodic memory and hippocampal volumes in a memory clinic population. Their findings indicate significant positive associations between volumes of the hippocampus bilaterally and memory function in the memory clinic sample, with evidence to suggest that the learning curve on a non-verbal memory measure represents a key marker of hippocampal integrity.

Aaron Bonner-Jackson, Shamseldeen Mahmoud, Justin Miller and Sarah J Banks
Alzheimer's Research & Therapy 2015, 7:61

Featured review: Lung disease as a determinant of cognitive decline and dementia

This review, from Dodd, summarises the evidence of an association between cognition, impaired lung function and obstructive lung disease. It goes on to examine the contribution of neuro-imaging to our understanding of the underlying pathophysiology. While the mechanisms of brain pathology and cognitive impairment are likely to be complex and multi-factorial, there is evidence to suggest a key role for occult cerebrovascular damage independent of traditional vascular risk factors, including smoking.

Alzheimer's Research & Therapy 2015 7:32


Alzheimer's Research & Therapy is edited by Douglas Galasko, Philip Scheltens and Todd Golde. Find the full Editorial Board here.


Recent articles

View all articles

Most accessed articles

View all articles

The 31st International Conference of Alzheimer’s Disease International

Alzheimer’s Disease International (ADI) is pleased to announce that the 31st International Conference of Alzheimer’s Disease International, will be held at the Budapest Conference Center (Hungary) from 21 – 24 April 2015.

Register and submit your abstract now and be a part of ADI’s leading international dementia conference which covers a broad range of topics, including, research, care and policy issues. Share your latest study with a global and diverse audience and ensure your voice is heard by leaders in the field.

Key dates:
Abstract submission: Monday 23 November 2015
Early Bird Deadline: Sunday 31 January 2015

Visit the conference website here.

Featured collection: Lewy Body Dementia

Edited by Ian McKeith and James Galvin, this special series takes a translational view of Lewy body dementia from bedside to bench and back. Visit our collections page to find our full list of special series, including thematic series on Innate immunity and Traumatic brain injury.


Alzheimer's Disease International logo

Alzheimer's Research & Therapy is affiliated to Alzheimer's Disease International (ADI), London, United Kingdom.